“Molecular Docking, Pre-ADME, And Pre-Tox Analysis Of Swainsonine And Castanospermine As Potential Glucokinase Activators” (2022) Journal of Pharmaceutical Negative Results, pp. 6456–6464. doi:10.47750/.